On February 9, 2022 Hubro Therapeutics reported that an abstract has been accepted for poster presentation at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) World Congress 2022, 8-13 April (Press release, Hubro Therapeutics, FEB 9, 2022, View Source [SID1234609537]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The abstract will be released on the AACR (Free AACR Whitepaper) 2022 website March 8, 16:30 ET ( AACR (Free AACR Whitepaper) Annual Meeting 2022 | April 8-13, 2022 | New Orleans ).

The poster will be scheduled for presentation during the ACCR congress 8-13 April 2022.

Poster: Detection of TGFbR2 a10→a9 frameshift mutation in cell free DNA of liquid biopsies from MSI-colorectal cancer patients.